TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLC's Executive Leadership Team | 08/05 08:01 | globenewswire.com |
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million | 07/26 08:01 | globenewswire.com |
TRxADE Health, Inc. Announces Special Cash Dividend | 07/09 08:05 | globenewswire.com |
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q | 05/29 16:05 | globenewswire.com |
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K | 04/23 16:05 | globenewswire.com |
Why Is Trxade Health (MEDS) Stock Up 230% Today? | 02/20 08:14 | investorplace.com |
Trxade health, Inc files its 3Q 10Q | 01/17 09:07 | globenewswire.com |
TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q. | 11/29 18:13 | globenewswire.com |
TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023. | 10/17 08:05 | globenewswire.com |